A detailed history of Voya Investment Management LLC transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Voya Investment Management LLC holds 10,712 shares of COLL stock, worth $312,147. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,712
Previous 10,964 2.3%
Holding current value
$312,147
Previous $353,000 17.0%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$31.4 - $39.07 $7,912 - $9,845
-252 Reduced 2.3%
10,712 $413,000
Q2 2024

Dec 03, 2024

BUY
$31.36 - $39.99 $7,902 - $10,077
252 Added 2.35%
10,964 $353,000
Q2 2024

Aug 14, 2024

SELL
$31.36 - $39.99 $533 - $679
-17 Reduced 0.15%
10,964 $353,000
Q1 2024

Dec 06, 2024

BUY
$31.23 - $40.91 $8,400 - $11,004
269 Added 2.51%
10,981 $426,000
Q1 2024

May 15, 2024

SELL
$31.23 - $40.91 $97,937 - $128,293
-3,136 Reduced 22.21%
10,981 $426,000
Q4 2023

Feb 14, 2024

SELL
$21.16 - $30.8 $5,395 - $7,854
-255 Reduced 1.77%
14,117 $434,000
Q3 2023

Nov 14, 2023

BUY
$21.23 - $24.28 $5,095 - $5,827
240 Added 1.7%
14,372 $321,000
Q2 2023

Aug 14, 2023

BUY
$21.06 - $24.0 $22,176 - $25,272
1,053 Added 8.05%
14,132 $303,000
Q1 2023

May 15, 2023

SELL
$23.0 - $29.88 $5,060 - $6,573
-220 Reduced 1.65%
13,079 $313,000
Q2 2022

Aug 15, 2022

SELL
$14.22 - $20.88 $18,486 - $27,144
-1,300 Reduced 8.9%
13,299 $236,000
Q1 2022

May 16, 2022

BUY
$17.2 - $22.5 $11,506 - $15,052
669 Added 4.8%
14,599 $297,000
Q4 2021

Feb 14, 2022

SELL
$17.5 - $21.35 $5,757 - $7,024
-329 Reduced 2.31%
13,930 $260,000
Q2 2021

Aug 16, 2021

SELL
$21.74 - $25.28 $25,283 - $29,400
-1,163 Reduced 7.54%
14,259 $337,000
Q1 2021

May 17, 2021

BUY
$19.25 - $26.1 $10,337 - $14,015
537 Added 3.61%
15,422 $366,000
Q4 2020

Feb 16, 2021

BUY
$17.83 - $22.29 $53,935 - $67,427
3,025 Added 25.51%
14,885 $298,000
Q2 2020

Aug 14, 2020

SELL
$15.49 - $23.51 $70,975 - $107,722
-4,582 Reduced 27.87%
11,860 $208,000
Q1 2020

May 15, 2020

BUY
$13.89 - $25.45 $10,139 - $18,578
730 Added 4.65%
16,442 $268,000
Q4 2019

Feb 14, 2020

BUY
$10.7 - $22.24 $24,727 - $51,396
2,311 Added 17.24%
15,712 $323,000
Q2 2019

Aug 14, 2019

BUY
$10.62 - $16.59 $10,524 - $16,440
991 Added 7.99%
13,401 $176,000
Q4 2018

Feb 14, 2019

BUY
$14.78 - $19.68 $11,454 - $15,252
775 Added 6.66%
12,410 $213,000
Q2 2018

Aug 14, 2018

BUY
$21.79 - $28.29 $14,969 - $19,435
687 Added 6.28%
11,635 $277,000
Q4 2017

Feb 14, 2018

BUY
$9.3 - $19.14 $8,732 - $17,972
939 Added 9.38%
10,948 $202,000
Q3 2017

Nov 14, 2017

BUY
$9.15 - $11.97 $91,582 - $119,807
10,009
10,009 $105,000

Others Institutions Holding COLL

About COLLEGIUM PHARMACEUTICAL, INC


  • Ticker COLL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 34,126,200
  • Market Cap $994M
  • Description
  • Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...
More about COLL
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.